473A Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Adaptimmune Therapeutics PLC

Watchlist Manager

Watchlist

Price: 0.012 EUR -20% Market Closed

Market Cap: €5.5m

A	Adaptimmune Therapeutics PLC SWB:473A	UK
	Novelstem International Corp OTC:NSTM	US
X	Xiangcai Co Ltd SSE:600095	CN
F	First National Equities Ltd KAR:FNEL	PK
	Enteq Technologies PLC F:5EQ	UK
L	Liberty One Lithium Corp XBER:L1TA	CA
	Franklin BSP Lending Corp OTC:BDVC	US
	Smalto SA PAR:MLSML	FR
	Comstock Metals Ltd XTSX:CSL	CA

Profitability Summary

Adaptimmune Therapeutics PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

32%

Sustainable 3Y Average Gross Margin

17%

Negative Operating Margin

-223%

Negative 3Y Average Operating Margin

-219%

Declining Operating Margin

-158% > -223%

Negative Net Margin

-261%

Negative 3Y Average Net Margin

-204%

Declining Net Margin

-129% > -261%

Negative Free Cash Flow Margin

-296%

Negative 3Y Average Free Cash Flow Margin

-206%

Declining Free Cash Flow Margin

-204% > -296%

Negative ROE

-1 341%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-91%

Declining ROIC

-97% > -153%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.